Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsProf. Arnold von Eckardstein University of Zurich, Switzerland
1 TalkBiography
Arnold von Eckardstein studied medicine in Giessen and Kiel and then specialized in laboratory medicine and clinical chemistry in Frankfurt and Münster (Germany). Since 2001, he has been professor at the medical faculty of the University of Zurich and the director of the Institute of Clinical Chemistry at the University... read moreHospital of Zurich. His main research interests include risk factors and biomarkers of cardiovascular and metabolic diseases as well as structure, function, and metabolism of high density lipoproteins (HDL) and sphingolipids. He has published more than 450 original and review papers in international peer reviewed scientific journals. Currently, Arnold von Eckardstein is the Editor-in-Chief of Atherosclerosis as well as a member of the Editorial Boards of Arteriosclerosis, Thrombosis and Vascular Biology; BBA Molecular and Cell Biology of Lipids; Cardiovascular Research, and European Heart Journal. Previously, he served as the Chairman of the European Lipoprotein Club, the Swiss and German Atherosclerosis Societies, and the Swiss Society of Clinical Chemistry as well as the Secretary of the European Atherosclerosis Society.